DNIB UNWIND INC Inactive Instrument
Company DNIB Unwind Inc OTC Bulletin Board
Equities
BINDQ
US05548N1072
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
Stephen Zale
CTO | Chief Tech/Sci/R&D Officer | 68 | 01/06/01 |
Tom Baker
IRC | Investor Relations Contact | - | - |
Neil Bander
PRN | Corporate Officer/Principal | - | - |
| Corporate Officer/Principal | - | 24/16/24 | |
James L. Wright
PRN | Corporate Officer/Principal | 76 | 01/07/01 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Corporate Officer/Principal | - | 24/16/24 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 20,886,802 | 17,860,424 ( 85.51 %) | 0 | 85.51 % |
Company contact information
DNIB Unwind, Inc.
333 South Grand Avenue Suite 4100
90071, Los Angeles
+617-491-3400
http://bindtherapeutics.com
Sector
| 1st Jan change | Capi. | |
|---|---|---|
| +8.63% | 11TCr | |
| +13.17% | 11TCr | |
| -12.76% | 2.22TCr | |
| -2.42% | 2.13TCr | |
| -7.19% | 1.75TCr | |
| -39.93% | 1.72TCr | |
| +6.67% | 1.41TCr | |
| +33.90% | 1.22TCr | |
| -28.60% | 783.09Cr |
- Stock Market
- Equities
- BINDQ Stock
- BINDQ Stock
- Company DNIB Unwind Inc